IDEAYA Biosciences increases director stock option grants; votes at annual meeting

IDEAYA Biosciences, Inc.

Initial director stock option grant increased from 22,000 to 32,400 shares.
Annual director stock option grant increased from 11,000 to 16,200 shares.
Three Class I directors elected: Yujiro Hata (41.3M for), Garrett Hampton (36.4M), Catherine Mackey (41.0M).
Ratification of PricewaterhouseCoopers as auditor for 2023 with 44.6M for, 49,514 against.
Board approved compensation changes on June 6, 2023, based on peer group data.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

IDEAYA Biosciences, Inc. shareholders approved Ratification of the selection, by the Audit Committee of the Board of Directors of the Company, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2023 at the 2023-06-07 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-07

Exact text from the filing

Proposal 2 . The ratification of the selection, by the Audit Committee of the Board of Directors of the Company, of PricewaterhouseCoopers LLP as the independent registered public accounting firm of the Company for the year ending December 31, 2023: Votes For Votes Against Abstentions 44,628,878 49,514 999

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

IDEAYA Biosciences, Inc. shareholders approved Election of three Class I directors to hold office until the 2026 annual meeting of stockholders or until their respective successors are elected at the 2023-06-07 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-07

Exact text from the filing

Proposal 1. The election of three Class I directors to hold office until the 2026 annual meeting of stockholders or until their respective successors are elected: Nominee Votes For Votes Withheld Broker Non-Votes Yujiro S. Hata 41,311,283 1,117,424 2,250,384 M. Garret Hampton, Ph.D. 36,443,001 5,985,706 2,250,384 Catherine J. Mackey, Ph.D. 40,989,747 1,438,960 2,250,384

View on SEC.gov

Browse all shareholder votes →

IDEAYA Biosciences, Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-027259

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.